Artrya Limited (AYAUF) Discusses Commercial Agreement With Huntsville Hospital Health System and Strategic Go-To-Market Progress Transcript
Artrya Limited (AYAUF) Discusses Commercial Agreement With Huntsville Hospital Health System and Strategic Go-To-Market Progress October 6, 2026 9:00 PM EDT
Company Participants
John Konstantopoulos – Co-Founder & CEO
Clayton Hatch – Chief Financial Officer
Conference Call Participants
David Allen – Hawkesbury Partners Pty Limited
Presentation
David Allen
Hawkesbury Partners Pty Limited
We’re going to discuss Artrya’s recently signed commercial agreement with the Huntsville Hospital Health System. My name is David Allen from Hawkesbury Partners. I’ll be your host today for the call and joining us from Artrya is John Konstantopoulos, CEO and Co-Founder; and with him also is Clayton Hatch, Chief Financial Officer.
We will be doing a quarterly call later in this month. So the operational matters will be dealt with then. Today’s focus is very much around Huntsville and the commercial achievements that it represents. I’d like to add that this call is going to be recorded. [Operator Instructions]
I’d like to now hand over the call to John Konstantopoulos to start us off today.
John Konstantopoulos
Co-Founder & CEO
Thanks, David, and thank you, everybody, for joining us today. And I’m really pleased to be speaking to you about this really important commercial milestone for us as a company, which is the signing of this 5-year commercial agreement with the Huntsville Hospital Health System. And there’s really 4 messages I want investors to take away from today’s call.
The first one and probably the most important one is that Huntsville is the first SAPPHIRE participant that we’ve now converted into a commercial customer. And this is really important early validation on our go-to-market strategy that we’ve been not only communicating to the market, but been pushing and pursuing in the background quite heavily over the last few months by using some of the clinical work that we’ve been
